Article Per Year (5 Year)
p-Index From 2021 - 2026
6.103
P-Index
This Author published in this journals
All Journal Jurnal Kedokteran Syiah Kuala Jurnal Farmasi Klinik Indonesia Medika Tadulako Journal of Islamic Pharmacy Preventif: Jurnal Kesehatan Masyarakat Jurnal Profesi Medika: Jurnal Kedokteran dan Kesehatan Syntax Literate: Jurnal Ilmiah Indonesia JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Farmasains : Jurnal Ilmiah Ilmu Kefarmasian JRST (Jurnal Riset Sains dan Teknologi) Majalah Farmasi dan Farmakologi (Trends in Pharmacy and Pharmaceutical Sciences) JRB-Jurnal Riset Bisnis JSFK (Jurnal Sains Farmasi & Klinis) JFL : Jurnal Farmasi Lampung PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) Jurnal Ilmu Kefarmasian Indonesia Pharmaceutical Journal of Indonesia Majalah Farmasetika Pharmacoscript Jurnal Farmamedika (Pharmamedica Journal) Health Information : Jurnal Penelitian PREPOTIF : Jurnal Kesehatan Masyarakat Budapest International Research and Critics Institute-Journal (BIRCI-Journal): Humanities and Social Sciences Jurnal Farmagazine Hubungan Tingkat Pengetahuan Petugas Pengelola Obat dengan Tingkat Ketersediaan Obat Di Puskesmas Kota Malang Jurnal Ekonomi Healthy Tadulako Journal (Jurnal Kesehatan Tadulako) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Medical Sains : Jurnal Ilmiah Kefarmasian Pharmaceutical Sciences and Research (PSR) Sciences of Pharmacy Eduvest - Journal of Universal Studies Innovative: Journal Of Social Science Research Medical Sains : Jurnal Ilmiah Kefarmasian Media Penelitian dan Pengembangan Kesehatan Jurnal Sains dan Kesehatan Jurnal Ilmiah Manuntung: Sains Farmasi dan Kesehatan Jurnal Ilmu Kesehatan Masyarakat
Yusi Anggriani
Universitas Pancasila
Religion Aerospace Engineering Agriculture, Biological Sciences & Forestry Arts Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Civil Engineering, Building, Construction & Architecture Computer Science & IT Decision Sciences, Operations Research & Management Dentistry Economics, Econometrics & Finance Education Engineering Environmental Science Health Professions Immunology & microbiology Law, Crime, Criminology & Criminal Justice Materials Science & Nanotechnology Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences Other

Published : 83 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 83 Documents
Search

 5   6   7   8   9 
The role of pharmacist counseling for patient with type 2 diabetes mellitus and its impact on blood glucose control and quality of life at RSUD Pasar Minggu Hardi, Devita; Anggriani, Yusi; Purba, Fredrick Dermawan
JURNAL ILMU KEFARMASIAN INDONESIA Vol. 23 No. 1 (2025): JIFI
Publisher : Faculty of Pharmacy, Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v23i1.1685

Abstract

Quality of life is an important aspect for patients with type 2 diabetes mellitus (T2DM). Pharmacist counseling is a non-pharmacological effort that can be provided to improve quality of life and control blood glucose levels. This study aimed to determine the effect of pharmacist-led therapeutic counseling for T2DM patients on improving their quality of life and reducing blood glucose levels. The study used a quasi-experimental nonequivalent control group design, with pretest and posttest assessments conducted before and after the intervention at RSUD Pasar Minggu, South Jakarta. A total of 194 T2DM patients participated in the study, with 97 patients in both the intervention and control groups. Quality of life was measured using the EQ-5D-5L and EQ-VAS questionnaires, along with fasting blood glucose levels. Measurements were taken three times: before the intervention, and one month and two months after the intervention. Paired data were analyzed using the Wilcoxon test, while unpaired data were analyzed using the Mann-Whitney test at a significance level of 0.05. Counseling significantly improved EQ-5D-5L scores (Δ=0.06; p<0.001) and EQ-VAS scores (Δ=6.40; p<0.001), as well as reduced fasting blood glucose levels (Δ=-12.10 mg/dL; p<0.001) in the intervention group after the intervention. The impact of counseling was particularly significant in the pain/discomfort and anxiety/depression domains. However, no significant correlation was found between quality of life and fasting blood glucose levels in this study (p>0.05). Pharmacist counseling conducted at RSUD Pasar Minggu had a positive and significant impact on improving the quality of life and treatment outcomes related to blood glucose reduction.
Analysis of the Implementation of Drug Control Category A with MMSL in Hospital Pharmacy Installation on Drug Values, ITOR and Stock Out Herayanti Hermawan; Yusi Anggriani; Hesty Utami Ramadaniati; Cipto Darmodjati Kumolo
JRST (Jurnal Riset Sains dan Teknologi) Volume 9 No. 2 September 2025: JRST
Publisher : Universitas Muhammadiyah Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30595/jrst.v9i2.26723

Abstract

Effective drug management is crucial for enhancing both economic performance and patient health outcomes in healthcare settings. This study aims to evaluate the implementation of drug inventory control using the Minimum Maximum Stock Level (MMSL) method at Hospital “X” in Purwakarta. Employing an experimental research design, this study conducted a comparative analysis of drug consumption before and after the application of the MMSL method, focusing on key metrics such as inventory value, inventory turnover (ITOR), and stock-out rates. The study's population comprised Category A medications, totaling 106 items, with an investment value of constituting 70.6% based on ABC analysis. Data were analyzed using the Wilcoxon signed-rank test to assess the significance of the MMSL method's impact. Our findings revealed notable differences in inventory value, ITOR, and stock-out rates between the baseline consumption (Rp. 830,213,174; ITOR 2.47; stock-out Rp. 6,967,778) and the MMSL implementation period (Rp. 627,919,174; ITOR 3.15; stock-out Rp. 3,776,316), with statistical significance levels of 0.045, 0.000, and 0.300, respectively. The results indicate that the MMSL method significantly enhances drug inventory management in the hospital setting, underscoring its effectiveness in optimizing pharmaceutical resource allocation.
Perceptions of criteria for substandard and falsified medicines among doctors, pharmacists, and patients in DKI Jakarta: a mixed-methods study Neneng Sri Purwaningsih; Yusi Anggriani; Hesty Utami Ramadaniat; Prih Sarnianto
Media Penelitian dan Pengembangan Kesehatan Vol. 36 No. 2 (2026): MEDIA PENELITIAN DAN PENGEMBANGAN KESEHATAN
Publisher : Poltekkes Kemenkes Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.34011/jmp2k.v36i2.3829

Abstract

Background: Indonesia continues to face challenges related to the circulation of substandard and counterfeit medicines. Perception plays an important role in shaping medicine-use behavior among healthcare professionals and patients. Objective: To identify factors associated with and dominant determinants of perceptions of substandard and counterfeit medicines among physicians, pharmacists, and patients in healthcare facilities in DKI Jakarta Province. Methods: A mixed-methods study with an explanatory design was conducted among 300 respondents, including 100 patients, 100 pharmacists, and 100 physicians. Quantitative samples were selected using cluster random sampling, while qualitative participants were recruited through purposive sampling. Data were collected through questionnaires and interviews and analyzed using chi-square tests and logistic regression (α<0.10). Results: The factors most strongly associated with perceptions of substandard medicines were knowledge among patients (95%), information among pharmacists (77%), and age among physicians (5%). For counterfeit medicines, the strongest associated factors were knowledge among patients (94%), gender among pharmacists (29%), and education among physicians (29%). Multivariate analysis showed that information was the dominant factor influencing perceptions of substandard medicines among patients (OR=2.000), pharmacists (OR=2.164), and physicians (OR=1.382). Perceptions of counterfeit medicines were predominantly influenced by knowledge, information, and education, respectively. Conclusion: Factors influencing perceptions of substandard and counterfeit medicines vary across respondent groups. Strengthening knowledge, education, and access to accurate information may improve awareness of substandard and counterfeit medicines.
Cost Analysis and Treatment of Covid-19 Patients with Comorbidities at Rspad Gatot Soebroto Petrus Kabul Togarma; Yusi Anggriani; Hesty Utami R; Dewiyana Andari K
Eduvest - Journal of Universal Studies Vol. 4 No. 9 (2024): Journal Eduvest - Journal of Universal Studies
Publisher : Green Publisher Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59188/eduvest.v4i9.3794

Abstract

The COVID-19 pandemic has significantly affected the global health sector, especially in patients with comorbidities such as type-2 diabetes mellitus and hypertension. Patients with these comorbidities require special attention and proper handling during the COVID-19 treatment process, given the higher risk of complications in this group. Gatot Soebroto Army Hospital, as a referral center for COVID-19 in Indonesia, faces the complexity of handling patients who often have complicated clinical conditions which are also related to the costs required. Therefore, analyzing the cost and treatment of COVID-19 patients who also suffer from comorbidities such as hypertension, type-2 diabetes mellitus, type-2 diabetes mellitus and hypertension is essential to improve care management. This study took place from January to July 2021 at Gatot Soebroto Army Hospital. The purpose of the study was to determine the cost and treatment of COVID-19 and the relationship between severity and outcomes. The method used was retrospective observational in COVID-19 patients with these comorbidities. The results showed that the largest cost expenditure came from room and accommodation costs. The highest average total cost came from a combination of comorbid hypertension and type-2 DM. The frequently used treatment profile showed antiviral therapy (favipirapir), antibiotics (Levofloxacin and Azithromycin), anticoagulants (heparin), corticosteroids (dexamethasone), and symptomatic (paracetamol). Improvement in clinical condition was the highest clinical outcome. The result of Chi-Square test analysis between severity and clinical outcome was significant (p-value 0.007<0.05). In conclusion, the treatment profile is adjusted to the clinical condition and the severity of COVID-19 affecting the clinical outcome.
PENGARUH PROLANIS TERHADAP OUTCOME KLINIK PASIEN DIABETES MELITUS TIPE 2 DI PUSKESMAS KECAMATAN PULOGADUNG Herty Nur Tanty; Yusi Anggriani; Sahat Saragi
Farmasains : Jurnal Ilmiah Ilmu Kefarmasian Vol. 6 No. 1 (2019)
Publisher : Universitas Muhammadiyah Prof. DR. HAMKA

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22236/farmasains.v6i1.2978

Abstract

Prolanis merupakan program dari PT. Askes (Persero) dalam upaya penanganan penyakit kronis pada pasien DM tipe 2. Jumlah pasien DM yang tergabung di Prolanis setiap tahunnya terus bertambah akan tetapi tidak disertai dengan kontinuitas kunjungan. Berdasarkan data jumlah peserta prolanis DM tipe 2 di Puskesmas Kecamatan Pulogadung yang sudah mengikuti prolanis minimal 6 bulan sejumlah 284 pasien. Tujuan penelitian ini adalah untuk mendapatkan perbedaan outcome klinik pasien prolanis dibanding pasien non prolanis dan mendapatkan hubungan antara kepatuhan dengan outcome klinik. Penelitian ini menggunakan desain cross sectional dengan alur penelitian retrospektif sebelum dan sesudah pasien bergabung dengan prolanis. Data diperoleh dari rekam medik dan data kunjungan pasien dengan menggunakan teknik total sampling. Hasil penelitian menunjukkan adanya perbedaan outcome klinik pasien DM tipe 2 yang mengikuti prolanis dengan pasien DM tipe 2 yang tidak mengikuti prolanis (p<0,05). Hasil penelitian menunjukkan adanya hubungan antara tingkat kepatuhan kunjungan dengan outcome klinik pasien prolanis dan non prolanis (p<0.05).
Outcome Klinik Berdasarkan Pemilihan Jenis Insulin pada Pasien Diabetes Mellitus Tipe 2 ida yuliasari; Yusi Anggriani; Hesty Utami R
Farmasains : Jurnal Ilmiah Ilmu Kefarmasian Vol. 9 No. 2 (2022)
Publisher : Universitas Muhammadiyah Prof. DR. HAMKA

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22236/farmasains.v9i2.6931

Abstract

Penggunaan insulin mengalami perubahan dimana insulin analog meningkat sedangkan insulin manusia mengalami penurunan. Hal ini perlu dikaji mengingat harga insulin analog lebih tinggi sehingga berdampak pada kenaikan biaya dan menyebabkan keterbatasan dalam penggunaannya yang akhirnya berdampak pada hasil terapi. Tujuan penelitian ini adalah untuk mengetahui pola penggunaan insulin dan outcome kliniknya. Penelitian dilakukan secara longitudinal time series dari data retrospektif  yang meliputi data pasien, data obat dan data pemeriksaan laboratorium. Jumlah sampel sebanyak 86 pasien terdiri dari 28 pasien pengguna insulin manusia dan 56 pasien pengguna insulin analog. Outcome klinik yang dianalisa adalah GDP, GDPP, dan HbA1C yang dinilai berdasarkan kategori terkendali baik, terkendali sedang dan terkendali buruk. Outcome klinik dianalisis dengan uji normalitas Kolmogorov Smirnov, selanjutnya dilakukan uji komparatif statistik non parametrik Kruskal Wallis dan uji Mann Whitney untuk melihat signifikansi perbedaan antar kategori. Insulin analog yang paling banyak digunakan adalah insulin analog tunggal. Hasil analisis menunjukkan tidak ditemukan perbedaan outcome klinik dari penggunaan insulin analog dan insulin manusia pada nilai GDP, GDPP dan HbA1C.
Cost-Effectiveness Analysis of Carboplatin-Paclitaxel, Cisplatin-Pemetrexed, and Carboplatin-Gemcitabine Chemotherapy Regimens in Patients with Non-Small Cell Lung Cancer at Persahabatan Central General Hospital Melinda, Venni; Anggriani, Yusi; Khairani, Sondang; Nurhayati, Fitri
Sciences of Pharmacy Volume 5 Issue 3 (2026)
Publisher : ETFLIN

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0502685

Abstract

Platinum-based chemotherapy remains an important treatment option for patients with advanced non-small cell lung cancer (NSCLC), particularly in settings where reimbursement and resource allocation are major considerations. A retrospective observational cost-effectiveness study was conducted using medical records and billing data from adult patients with NSCLC who received carboplatin–paclitaxel, cisplatin–pemetrexed, or carboplatin–gemcitabine in 2023. Effectiveness outcomes included the one-year survival rate (%) and median progression-free survival (PFS). Costs were calculated based on direct medical expenses over six chemotherapy cycles. Cost-effectiveness was assessed using ACER, ICER, and dominance analysis. A total of 101 patients were included: 81 received carboplatin and paclitaxel, 14 received cisplatin and pemetrexed, and 6 received carboplatin and gemcitabine. Mean direct medical costs were IDR 27,588,547, IDR 41,214,281, and IDR 47,471,752, respectively. No statistically significant differences were observed in one-year survival rate or median PFS among the regimens, although interpretation should consider the unequal sample sizes (81 vs. 14 vs. 6), which limit statistical power. Based on one-year survival, carboplatin–paclitaxel had the lowest ACER and dominated the other regimens by providing higher observed survival at lower cost. Based on median PFS, cisplatin–pemetrexed provided longer PFS than carboplatin–paclitaxel but at a higher cost, requiring ICER-based interpretation. Carboplatin–paclitaxel was associated with the lowest direct medical cost and the most favorable cost-effectiveness profile based on one-year survival among the evaluated regimens. However, conclusions should be interpreted cautiously because of the retrospective design, small and unequal group sizes, and potential confounding by baseline clinical characteristics.
Hubungan antara Partisipasi dalam Program Prolanis dan Kadar Gula Darah Puasa pada Pasien Diabetes Tipe 2: Data dari Kota dengan Prevalensi Tinggi di Jakarta Faradiba Faradiba; Yusi Anggriani; Elsa Maulidya
PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), Vol. 23 No. 01 Juli 2026
Publisher : Universitas Muhammadiyah Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30595/pharmacy.v23i1.29757

Abstract

Berdasarkan laporan International Diabetes Federation (IDF 2021), Indonesia menempati peringkat ke-5 dalam prevalensi diabetes di dunia. Untuk mengatasi hal tersebut, asuransi kesehatan nasional Indonesia (BPJS-JKN) menyelenggarakan program untuk manajemen penyakit kronis bernama Prolanis, yang termasuk penyakit diabetes melitus tipe 2. Program ini menawarkan konsultasi rutin untuk pasien, skrining, serta kunjungan rumah. Tujuan studi ini adalah mendeskripsikan efektivitas program Prolanis melalui profil kadar gula darah (GDP) pada pasien diabetes tipe 2 di puskesmas-puskesmas di Jakarta. Analisis observasional dengan pendekatan cross-sectional komparatif dilakukan pada 274 pasien Prolanis dan 242 pasien non-Prolanis. Data didapatkan dari rekam medis dan presensi kehadiran Prolanis. Mann-Whitney digunakan untuk menilai perbedaan 1) profil GDP antara Prolanis dan non-Prolanis, 2) profil GDP antarkelompok puskesmas, dan 3) jumlah kehadiran untuk kontrol pasien Prolanis dan non-Prolanis. Chi-square digunakan untuk menganalisis hubungan antara kontrol rutin dan profil GDP pada kedua kelompok. Meskipun kedua kelompok tidak mencapai target GDP, hasil penelitian menunjukkan adanya indikasi perbedaan yang signifikan antara kelompok Prolanis dan kelompok non-Prolanis. Puskesmas yang mengadopsi semua kegiatan Prolanis memiliki GDP yang lebih rendah dibandingkan puskesmas yang mengadopsi secara parsial. Tidak ada hubungan antara kontrol rutin dan profil GDP. Implementasi Prolanis diperlukan, tetapi sejauh ini belum memadai. Pemerintah harus menjadikan potensi Prolanis sebagai program pengontrol penyakit yang lebih serius, dengan lebih berfokus pada kualitas implementasi secara menyeluruh.
Analysis of Risk Factors of Chronic Kidney Disease on Patients With Hemodialysis in Tangerang District Hospital Arman; Yusi Anggriani; Hesty Utami R
Jurnal Ilmu Kesehatan Masyarakat Vol. 10 No. 2 (2019): Jurnal Ilmu Kesehatan Masyarakat (JIKM)
Publisher : Faculty of Public Health, Universitas Sriwijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26553/jikm.2019.10.2.112-125

Abstract

Chronic kidney disease (CKD) is a major world health challenge in the 21st centuries. The prevalence of CKD in Indonesia based on the doctor's diagnosis is 0.2% while for Tangerang prevalence at 0.1%. There are no clear data of the predisposing factor of CKD in Banten province, especially in Tangerang. The purpose of this study was to analyze the risk factors CKD on patients with hemodialysis in Tangerang District Hospital. This study is an observational analytic research with case-control and cross sectional approach conducted in August to September 2017 at the Tangerang District Hospital. with 70 respondents in case group and 70 respondents in control group. The result of the bivariate analysis showed that 15 of 19 risk factors significantly (p ≤ 0.05) increased the risk of CKD with OR range 2,043 to 4,235. The result of multivariate analysis with logistic regression test showed that the most dominant risk factor for CKD was hypertension with OR 21,806 (95% C.I. 1,015- 486,554) and p = 0,049. There are 15 risk factors that could increase the risk of CKD. the most dominant risk factor for CKD was hypertension
Analisis Dampak Kebijakan E-Catalogue terhadap Profil Pengadaan Obat di Instalasi Farmasi RSUP Fatmawati Setyawati Permata; Yusi Anggriani; Maria Sukmawati Lesilolo
PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), Vol. 17 No. 01 Juli 2020
Publisher : Universitas Muhammadiyah Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30595/pharmacy.v17i1.4682

Abstract

Pemerintah Indonesia mengendalikan harga secara langsung melalui LKPP (Lembaga Kebijakan Pengadaan Barang/Jasa Pemerintah) dengan menetapkan harga e-catalogue untuk pengadaan obat bagi pasien yang menggunakan sistem pembiayaan JKN-BPJS (Jaminan Kesehatan Nasional-Badan Penyelenggara Jaminan Sosial). Penelitian ini bertujuan untuk mengetahui dampak kebijakan e-catalogue pada profil pengadaan obat di Instalasi Farmasi Rumah Sakit Umum Fatmawati, baik yang ada dalam daftar e-catalogue dan non e-catalogue. Penelitian ini menggunakan desain penelitian observasional, analitik kuantitatif dengan longitudinal time series. Pengumpulan data dilakukan secara retrospektif menggunakan data harga pengadaan obat dari Sistem Informasi Rumah Sakit pada periode Januari 2011-Desember 2016. Hasil penelitian pada profil pengadaan obat menunjukkan persentase pengadaan obat e-catalogue, setelah penerapan e-catalogue (20,0-29,4%) lebih tinggi dari sebelumnya (10,0-17,2%), dan obat non e-catalogue lebih rendah setelah penerapan e-catalogue (70,6-80,0%) dari sebelumnya (82,8-90,0%). Persentase pengadaan obat setelah penerapan e-catalogue berdasarkan jenisnya: obat e-catalogue generik lebih tinggi (4,5-8,0%) dibandingkan sebelumnya (1,2-4,4%), obat generik non e-catalogue lebih tinggi (12,7-16,2%) daripada sebelumnya (4,4-14,1%), obat dengan nama dagang e-catalogue lebih tinggi (12,3-17,8%) daripada sebelumnya (5,6-12,4%), obat dengan nama dagang non e-catalogue lebih rendah (53,1-65,7%) dari sebelumnya (67,4-79,9%), obat paten e-catalogue lebih tinggi (2,7-4,2%) dari sebelumnya (1,8-3,6%), obat paten non e-catalogue hampir sama (1,4-1,9%) dari sebelumnya (1,1-1,9%). Kesimpulan dari studi ini adalah kebijakan e-catalogue meningkatkan pengadaan obat, baik obat generik, obat nama dagang, maupun obat paten yang ada dalam daftar e-catalogue.
Co-Authors Abillah, Syamsudin Ade Rosanti AGUS PURWANGGANA Agusdini Banun Agusdini Banun Saptaningsih Ahmad Subhan AHMAD SUBHAN Ahriansyah, Andi Alfina Rianti Alfina Rianti Andalucia, Rizka Annisa Nadya Pratiwi Annisa, Rifka ARIES MERYTA Aries Meryta Arif Rahmandani Aris Aris Aritonang, MGS Arman Astrid Kartika Sari Ath-Thobari, Jarir Atmiroseva Atmiroseva Banun, Agusdini Briliana Sabirin Candra Junaedi Chaerul Y, Ricky Chandra Widianti Cipto Darmodjati Kumolo Citra Jaya Debi Susanti Desweri Muhareni Dewiyana Andari K Dian Khairunisa Dian Ratih Laksmitawati Dosi Ahmad Yani Dosi Ahmad Yani Dwi Puspita Sari, Dwi Puspita Eduward Gunawan Edwina Dharmawati Elisabeth Ninung Yuliarti Elisna Syahruddin Elsa Maulidya Erfan Chandra Nugraha Erna Kristin Evy Yunihastuti Fadhlia Majidiah Faradiba Faradiba Faridah Syamsiah Fitri Nurhayati Fitriana, Irna Fredrick D. Purba Fredrick Dermawan Purba Fredrik Dermawan Purba Hanafy, Dudy Arman Hardi, Devita Harissa, Nola Herayanti Hermawan Herty Nur Tanty Herty Nur Tanty Hesty Utami Hesty Utami Hesty Utami R Hesty Utami R Hesty Utami R Hesty Utami R Hesty Utami Ramadaniat Hidayat Hidayat ida yuliasari Ilham Maulana Irmin Irmin Irna Fitriana Jayati, Turpuk Mannaria Juju Jumiati L, Dian Ratih Leny Ramadhan M. Kenli Kendi Tampoliu Maria Sukmawati Lesilolo Maria Sukmawati Lesilolo Maura Linda Sitanggang Mawaddati Rahmi Mayasari, Yeshi Melinda, Venni MGS Aritonang MGS. Aritonang Mita Restinia Muhammad Reza Mulatsari, Esti Nanang Erlana Nanang Erlana Neneng Sri Purwaningsih Nurita Andayani NURLAYLI NURLAYLI Nurlela Nurlela Okpri Meila Petrus Kabul Togarma Pontoan, Jenny Prasasta Sutedjo Pratiwi, Annisa Nadya Prih Sarnianto Prih Sarnianto Prih Sarnianto Prih Sarnianto Prih Sarnianto R, Hesty Utami Ramadaniati, Hesty Utami Rasta Naya Pratita Reise Manninda Retnaningrum, Dyah RIA PUSPITA WARDHANI Rianti, Alfina Ricky Chaerul Yazid Rifka Annisa Rina Rosdiana Rochsismandoko Rochsismandoko Rosanti, Ade Rosdaniati Rosdaniati Rosiana, Rosiana Rulliani Bianca Wijaya S.Farm., M.Farm., Apt, Sondang Khairani Sabirin, Briliana Sahat Saragi Sahat Saragih Sari, Ratna Permana Sarnianto, Prih Sarnianto, Prih Sarwono Waspadji Septa, Tendry Setianti Haryani Setyawati Permata Siti Aisyah Siti Aisyah Suratni Suratni Suratni Suratni Tanty, Herty Nur Tarsinah Tarsinah Tarsinah, Tarsinah Tri Kusumaeni TRI KUSUMAENI Tri Kusumaeni Tri Kusumaeni Tri Kusumaeni Tri Kusumaeni, Hesty Utami R. Tri Murtini Trisna Lestari Umar Santosa Utami R, Hesty Venessya Cikita Mitakda Widya Wulan Ayu Puspitaningrum Wijaya, Rulliani Bianca William Nathanial Tj Wilson Wilson Wulan Puspitasari Wulan Puspitasari Y, Ricky Chaerul Yacob Ruru Yani, Dosi Ahmad Yati Sumiati Yati Sumiyati Yava Rony, Devi Yulia Trisna Yulia Trisna, Yulia Yuliani YULIANI Yulwa Juwita